Saturday's attack is the biggest on Saudi oil infrastructure since Saddam Hussein's invasion of Kuwait in 1990.Energyread more
Saudi Aramco is aiming to restore by Monday about a third of its crude output that was disrupted after drone attacks on two key oil facilities, The Wall Street Journal...Marketsread more
"Blaming Iran won't end disaster. Accepting our April '15 proposal to end war & begin talks may," Zarif said on Twitter.Energyread more
Oil prices are expected to jump as much as $10 per barrel after a coordinated drone strike hit Saudi Arabia's largest oil field, forcing the kingdom to cut its oil output in...Marketsread more
Apple's new iPhones can still send texts, download apps, and make video calls, but the company spends a lot of time and effort marketing its new phones as powerful photography...Technologyread more
The trucking industry is worth hundreds of billions of dollars per year. Uber is going after this market with Uber Freight, an online platform that matches truckers with...Technologyread more
Some U.S. manufacturers say tariffs, if targeted, will help address longstanding unfair trade practices like intellectual property theft.Traderead more
Supporters of a $15 minimum wage ballot initiative in Florida argue the state's inflation-tied pay hikes have not gone far enough.2020 Electionsread more
Saudi Arabia shut down half its oil production Saturday after drone strikes hit the world's largest oil processing facility in an attack claimed by Yemen's Houthi rebels.Politicsread more
Trusii's hydrogen water machines were supposed to help users with their health problems, but customers claim the company is involved in a giant scam.Technologyread more
The decoupling of the world's two weightiest economies seems as inescapable as its extent and global impact remains incalculable.Politicsread more
FRANKFURT, June 4 (Reuters) - German drugmaker Bayer has signed an alliance with Arvinas Inc to gain access to the U.S. biotech firm's experimental protein drugs and crop protection technology in a deal worth up to $750 million.
Under the pact, Arvinas will receive an upfront payment, pharmaceutical research and development (R&D) support and a direct equity investment of more than $60 million.
In addition, milestone payments linked to development achievements and commercial royalties could add up to slightly more $685 million, Bayer said in a statement on Tuesday.
Bayer, which is cutting jobs and revamping its drug development activities, has said it will seek to rely more on external partners to improve its prospects in pharmaceuticals development.
Arvinas is working on so-called proteolysis targeting chimeras that harness the body's own natural protein disposal system to degrade and remove disease-causing proteins.
Bayer, which acquired agricultural supplies company Monsanto last year, said it would also form a joint venture with Arvinas because the U.S. company's technology could also be used on farms to fight weeds and plant pests.
Arvinas shares were indicated more than 10 percent higher in pre-market U.S. trades. (Reporting by Ludwig Burger and Patricia Weiss; Editing by Mark Potter)